Factors Associated with the Development of Opportunistic Infections in HIV-1-Infected Adults with High CD4 + Cell Counts: A EuroSIDA Study.

Autor: Podlekareva, Daria, Mocroft, Amanda, Dragsted, Ulrik B., Ledergerber, Bruno, Beniowski, Marek, Lazzarin, Adriano, Weber, Jonathan, Clumeck, Nathan, Vetter, Norbert, Phillips, Andrew, Lundgren, Jens D.
Předmět:
Zdroj: Journal of Infectious Diseases; 9/1/2006, Vol. 194 Issue 5, p633-641, 9p
Abstrakt: Background. Limited data exist on factors predicting the development of opportunistic infections (OIs) at higher-than-expected CD4+ cell counts in human immunodeficiency virus (HIV) type 1-infected adults. Methods. Multivariate Poisson regression models were used to determine factors related to the development of groups of OIs above their respective traditional upper CD4+ cell count thresholds: group 1 (⩾100 cells/μL), OIs caused by cytomegalovirus, Mycobacterium avium complex, and Toxoplasma gondii; group 2 (⩾200 cells/μL), Pneumocystis pneumonia and esophageal candidiasis; and group 3 (⩾300 cells/μL), pulmonary and extrapulmonary tuberculosis. Results. In groups 1, 2, and 3, 71 of 9219, 125 of 7934, and 36 of 7838 patients, respectively, developed ⩾1 intragroup OI. The strongest predictor of an OI in groups 1 and 2 was current CD4+ cell count (for group 1, incidence rate ratio [IRR] per 50% lower CD4+ cell count, 5.37 [95% confidence interval {CI}, 3.71–7.77]; for group 2, 4.28 [95% CI, 2.98–6.14]). Injection drug use but not current CD4+ cell count predicted risk in group 3. Use of antiretroviral treatment was associated with a lower incidence of OIs in all groups, likely by reducing HIV-1 RNA levels (IRR per 1-log10 copies/mL higher HIV-1 RNA levels for group 1, 1.50 [95% CI, 1.15–1.95]; for group 2, 1.68 [95% CI, 1.40–2.02]; and for group 3, 1.89 [95% CI, 1.40–2.54]). Conclusion. Although the absolute incidence is low, the current CD4+ cell count and HIV-1 RNA level are strong predictors of most OIs in patients with high CD4+ cell counts. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index